Abstract: AI-based orchestration. In an embodiment, a recommendation engine is applied to a data pipeline representing company accounts. Engagement metric(s) are calculated based on activity data associated with the company accounts, and predictive model(s) are applied to the activity data and/or firmographic data associated with the company accounts to generate predictive output. A tactic recommendation model is applied to orchestration features, comprising the engagement metric(s) and predictive output, to generate recommended tactic(s). In addition, a contact recommendation model is applied to contact data to generate recommended contact(s). The recommended tactic(s) are combined with the recommend contact(s) to generate an orchestration, comprising recommended action(s), to be executed.

Abstract: The present application relates to pharmaceutical formulations and dosage forms of a lysine specific demethylase-1 (LSD1) inhibitor, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, including methods of preparation thereof, which are useful in the treatment of LSD1 mediated diseases such as cancer.

Abstract: In an example embodiment, a data structure is received and automatically reconciled with other data structures in a computer system by comparing fields such as dates, transaction amounts, and discount amounts. A user is alerted as to whether the matches or discrepancies occur by displaying a message in a user interface.

Abstract: In one embodiment, a local computer network includes profile information local identifications for multiple organizations. Remote profile information is stored on a remote computer network and transferred to the local network to perform secure transactions with other computer networks. Embodiments of the disclosure include linking remote and local identifications. In another embodiment, remote and local identifications are linked by generated multiple messages to different users in different roles to prevent fraud, for example.

Abstract: The present application relates to pharmaceutical formulations and dosage forms of a lysine specific demethylase-1 (LSD1) inhibitor, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, including methods of preparation thereof, which are useful in the treatment of LSD1 mediated diseases such as cancer.

Abstract: The present application relates to pharmaceutical formulations and dosage forms of a lysine specific demethylase-1 (LSD1) inhibitor, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, including methods of preparation thereof, which are useful in the treatment of LSD1 mediated diseases such as cancer.

Abstract: The present application relates to pharmaceutical formulations and dosage forms of a lysine specific demethylase-1 (LSD1) inhibitor, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, including methods of preparation thereof, which are useful in the treatment of LSD1 mediated diseases such as cancer.

Abstract: In an example embodiment, a data structure is received and automatically reconciled with other data structures in a computer system by comparing fields such as dates, transaction amounts, and discount amounts. A user is alerted as to whether the matches or discrepancies occur by displaying a message in a user interface.

Abstract: In one embodiment, a local computer network includes profile information local identifications for multiple organizations. Remote profile information is stored on a remote computer network and transferred to the local network to perform secure transactions with other computer networks. Embodiments of the disclosure include linking remote and local identifications. In another embodiment, remote and local identifications are linked by generated multiple messages to different users in different roles to prevent fraud, for example.